| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institute for Immunology, Ludwig-Maximilians-Universität München, Munich, Germany
Dendritic cells (DCs) loaded in vitro with Ag are used as cellular vaccines to induce Ag-specific immunity. These cells are thought to be responsible for direct stimulation of Ag-specific T cells, which may subsequently mediate immunity. In this study, in transgenic mouse models with targeted MHC class II expression specifically on DCs, we show that the DC vaccine is responsible only for partial CD4+ T cell activation, but to obtain optimal expansion of T cells in vivo, participation of endogenous (resident) DCs, but not endogenous B cells, is crucial. Transfer of Ag to endogenous DCs seems not to be mediated by simple peptide diffusion, but rather by DC-DC interaction in lymph nodes as demonstrated by histological analysis. In contrast, injection of apoptotic or necrotic DC vaccines does not induce T cell responses, but rather represents an immunological null event, which argues that viability of DC vaccines can be crucial for initial triggering of T cells. We propose that viable DCs from the DC vaccine must migrate to the draining lymph nodes and initiate a T cell response, which thereafter requires endogenous DCs that present transferred Ag in order induce optimal T cell expansion. These results are of specific importance with regard to the applicability of DC vaccinations in tumor patients, where the function of endogenous DCs is suppressed by either tumors or chemotherapy.
This article has been cited by other articles:
|
|
 |
|
  M. de Heusch, D. Blocklet, D. Egrise, B. Hauquier, M. Vermeersch, S. Goldman, and M. Moser Bidirectional MHC molecule exchange between migratory and resident dendritic cells J. Leukoc. Biol., October 1, 2007; 82(4): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Segura, C. Guerin, N. Hogg, S. Amigorena, and C. Thery CD8+ Dendritic Cells Use LFA-1 to Capture MHC-Peptide Complexes from Exosomes In Vivo J. Immunol., August 1, 2007; 179(3): 1489 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mendoza-Naranjo, P. J. Saez, C. C. Johansson, M. Ramirez, D. Mandakovic, C. Pereda, M. N. Lopez, R. Kiessling, J. C. Saez, and F. Salazar-Onfray Functional Gap Junctions Facilitate Melanoma Antigen Transfer and Cross-Presentation between Human Dendritic Cells J. Immunol., June 1, 2007; 178(11): 6949 - 6957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wiethe, M. Schiemann, D. Busch, L. Haeberle, M. Kopf, G. Schuler, and M. B. Lutz Interdependency of MHC Class II/Self-Peptide and CD1d/Self-Glycolipid Presentation by TNF-Matured Dendritic Cells for Protection from Autoimmunity J. Immunol., April 15, 2007; 178(8): 4908 - 4916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Celli, Z. Garcia, and P. Bousso CD4 T cells integrate signals delivered during successive DC encounters in vivo J. Exp. Med., November 7, 2005; 202(9): 1271 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Cox, M. North, M. Burke, H. Singhal, S. Renton, N. Aqel, S. Islam, and S. C. Knight Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes J. Leukoc. Biol., November 1, 2005; 78(5): 1142 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. H. Tan and H. C. O'Neill Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity J. Leukoc. Biol., August 1, 2005; 78(2): 319 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Segura, C. Nicco, B. Lombard, P. Veron, G. Raposo, F. Batteux, S. Amigorena, and C. Thery ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming Blood, July 1, 2005; 106(1): 216 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Driessens, M. Hamdane, V. Cool, T. Velu, and C. Bruyns Highly Successful Therapeutic Vaccinations Combining Dendritic Cells and Tumor Cells Secreting Granulocyte Macrophage Colony-stimulating Factor Cancer Res., November 15, 2004; 64(22): 8435 - 8442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Roberts, J. Yang, and F. Ronchese IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo Int. Immunol., October 1, 2004; 16(10): 1451 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Spaner Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells J. Leukoc. Biol., August 1, 2004; 76(2): 338 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsuyoshi, S. Senju, S. Hirata, Y. Yoshitake, Y. Uemura, and Y. Nishimura Enhanced Priming of Antigen-Specific CTLs In Vivo by Embryonic Stem Cell-Derived Dendritic Cells Expressing Chemokine Along with Antigenic Protein: Application to Antitumor Vaccination J. Immunol., January 15, 2004; 172(2): 776 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sporri and C. Reis e Sousa Newly Activated T Cells Promote Maturation of Bystander Dendritic Cells but Not IL-12 Production J. Immunol., December 15, 2003; 171(12): 6406 - 6413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Teitz-Tennenbaum, Q. Li, S. Rynkiewicz, F. Ito, M. A. Davis, C. J. Mcginn, and A. E. Chang Radiotherapy Potentiates the Therapeutic Efficacy of Intratumoral Dendritic Cell Administration Cancer Res., December 1, 2003; 63(23): 8466 - 8475. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
